5433182026-01-012026-03-315433182026-03-315433182025-03-315433182025-04-012026-03-315433182026-01-012026-03-31in-capmkt:OtherExpenses1Member5433182025-04-012026-03-31in-capmkt:OtherExpenses1Member5433182026-03-31OtherNoncurrentFinancialAssetsDomain15433182026-03-31OtherNoncurrentAssetsDomain15433182026-03-31OtherCurrentFinancialAssetsDomain15433182026-03-31OtherCurrentAssetsDomain15433182026-03-31OtherNoncurrentFinancialLiabilitiesDomain15433182026-03-31OtherNoncurrentLiabilitiesDomain15433182026-03-31OtherCurrentFinancialLiabilitiesDomain15433182026-03-31OtherCurrentLiabilitiesDomain15433182026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15433182025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15433182026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares543318CLEANNOTLISTEDINE227W01023Clean Science and Technology LimitedMain BoardEquity2025-04-012026-03-312026-05-142026-04-24INRMillionsQuarterlyFourth quarterSingle segmentOrganic Chemicals2026-05-1412:30:002026-05-1414:20:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31AuditedConsolidated24925300002795000025204800009913400000-808500003826000050000020821000058615000017436100007768700000776870000228180000-3403000019415000005827200000000582720000129000058401000010628000015.485.48005.485.481. The Statement has been prepared in accordance with the recognition and measurement principles laid down in India Accounting Standards prescribed under Section 133 of the Companies Act, 2013 read with Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time and the provisions of the Companies Act 2013 and other accounting principles. <BR> 2. The Board of Directors in their meeting held on May 14, 2026 have recommended, subject to approval of shareholders, final dividend of Rs. 4 /- per share for the year ended March 31, 2026. <BR> 3. The above results have been reviewed by the Audit Committee and thereafter approved and taken on record by the Board of Directors at its meeting held on May 14, 2026. The consolidated financial results for the year ended March 31, 2026 were subject to audit by the Statutory Auditors of the Company and the figures for the quarter ended March 31, 2026 and March 31, 2025, are the balancing figures between the audited figures in respect of the relevant full financial year and unaudited published year to date figures upto the end of the third quarter of the respective financial year. <BR> 4. Standalone information: <BR> Particulars Quarter Ended Year ended <BR> March 2026 Apr-March 2026 <BR> Revenue 1971.30 8153.35 <BR> Profit before tax 773.90 3356.11 <BR> Profit for the period/year 581.21 2512.17 <BR> Other comprehensive (loss) / income 1.44 2.18 <BR> Total comprehensive income 582.65 2514.35 <BR> 5. The Group is exclusively engaged in the business of manufacturing of organic chemicals. This in the context of the Ind AS 108 Operating Segments, is considered to constitute one single primary segment. <BR> 6. During the year ended March 31, 2026, 10,040 equity shares of Rs. 1/- each fully paid-up, were allotted upon exercise of the vested stock options pursuant to the Company's Employee Stock Option Scheme, 2021 (ESOP 2021). <BR> 7.During the quarter ended March 31, 2026, the Executive Directors voluntarily elected to forgo a substantial portion of their performance bonus entitlement for the financial year 2025-26. Accordingly, the provision for performance bonus recognised in the earlier quarters has been reversed to that extent, resulting in lower employee benefits expense for the quarter ended March 31, 2026 as compared to previous quarter ended December 31, 2025. <BR> 8. The consolidated results of the Group are available on the Company's website, www.cleanscience.co.in and also on the website of the BSE Limited, www.bseindia.com and National Stock Exchange of India Limited, www.nseindia.com, where the shares of the Company are listed.2025-04-012026-03-31AuditedConsolidated9565470000325550000989102000035967800000-24400000478670000354000077579000019639400006794320000309670000003096700000883740000-8359000080015000002296550000000022965500002190000229874000010628000011573143000021.6121.60021.6121.6Other expenses586150000Other expenses19639400007548010000117952000000517500000005778100000013640000591450000126420000488700009546020000153722000034715400002064190000280200000194000008581000006675970000156000068230000828298000017829000000106280000157314300001583771000015837710000000019670000196700000299250000019500000338420000047000000111035000011573500003770600001534410000483500002168000048430000165287000000199129000017829000000Other non-current financial assets13640000Other non-current assets48870000Other current financial assets858100000Other current assets68230000Other non-current financial liabilities19670000Other non-current liabilities19500000Other current financial liabilities377060000Other current liabilities483500003540000-42940000-73000000-463100000166900002590000016669000001691000007757900000106300000-14869000019500000-442400006900004926000074300008155000002300000-224950000222000000561440000365814000000091298000002745160000007586660000756616000000005390000201034000000000000000607000000000690000143100000-61690000-202507000000000050200000000637650000343000000-6360600008403000085000084880000195320000280200000Remeasurements of post employment benefit obigations.17500001750000Remeasurements of post employment benefit obigations.2930000293000046000074000012900002190000AuditedtruePrice Waterhouse Chartered Accountants LLPtrue2026-11-30